Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.71
-0.19 (-1.37%)
At close: Jun 23, 2026, 4:00 PM EDT
12.60
-1.11 (-8.10%)
After-hours: Jun 23, 2026, 6:26 PM EDT
Korro Bio Employees
Korro Bio had 49 employees as of March 31, 2026. The number of employees decreased by 63 or -56.25% compared to the same quarter last year.
Employees
49
Change
-63
Growth
-56.25%
Revenue / Employee
$78,408
Profits / Employee
-$2,316,286
Market Cap
197.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 49 | -63 | -56.25% | 49 | 0 |
| Dec 31, 2025 | 58 | -46 | -44.23% | 58 | 0 |
| Sep 30, 2025 | 87 | -8 | -8.42% | 87 | 0 |
| Jun 30, 2025 | 92 | 0 | - | 92 | 0 |
| Mar 31, 2025 | 112 | 18 | 19.15% | 112 | 0 |
| Dec 31, 2024 | 104 | 2 | 1.96% | 104 | 0 |
| Sep 30, 2024 | 95 | -1 | -1.04% | 95 | 0 |
| Jun 30, 2024 | 92 | 4 | 4.55% | 92 | 0 |
| Mar 31, 2024 | 94 | 6 | 6.82% | 94 | 0 |
| Dec 31, 2023 | 102 | - | - | 101 | 1 |
| Sep 30, 2023 | 96 | - | - | 95 | 1 |
| Jun 30, 2023 | 88 | - | - | 88 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| LENZ Therapeutics | 152 |
| Tonix Pharmaceuticals Holding | 142 |
| MediWound | 121 |
| Alector | 103 |
| Immunic | 95 |
| Compugen | 75 |
| OnKure Therapeutics | 45 |
| Unicycive Therapeutics | 22 |
KRRO News
- 25 days ago - Korro Bio initiated with an Outperform at LifeSci Capital - TheFly
- 27 days ago - Korro to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Korro Bio selects KRRO-111 as development candidate - TheFly
- 5 weeks ago - Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) - GlobeNewsWire
- 5 weeks ago - Korro Bio price target lowered to $15 from $20 at H.C. Wainwright - TheFly
- 5 weeks ago - Korro Bio initiated with a Buy at Citi - TheFly
- 5 weeks ago - Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Korro Bio upgraded to Buy from Hold at JonesResearch - TheFly